Type 2 diabetes mellitus in China: A preventable economic burden

American Journal of Managed Care

Volumn 15, Issue 9, 2009, Pages 593-601

  Wang, Weibing ^a   McGreevey, William P ^b   Fu, Chaowei ^a   Zhan, Siyan ^c   Luan, Rongsheng ^d   Chen, Weiqing ^e   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c PEKING UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ADULT; ARTICLE; BUDGET; CALCULATION; CARDIOVASCULAR DISEASE; CHINA; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PRIORITY JOURNAL; PROBABILITY; SAMPLING; SCREENING; TERTIARY HEALTH CARE; AGED; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; ECONOMICS; MASS SCREENING; MIDDLE AGED; PUBLIC HEALTH; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PUBLIC HEALTH;

EID: 70349411679     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. International Diabetes Federation. Diabetes Atlas. 3rd ed. Brussels, Belgium: International Diabetes Federation; 2006.
2. Qi X, Wang Y. Report on Chronic Disease in China. Beijing, China: National Center for Disease Control and Prevention; 2006.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5): 1047-1053.
4. Li LM, Rao KQ, Kong LZ, et al; The Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002 [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26(7):478-484.
5. Zhang J, Wang CR, Fu P, et al. Study on diabetes prevalence in urban China [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi. 2007;41(1):4-7.
6. Xu L, Xie X, Wang S, Wang Y, Jonas JB. Prevalence of diabetes mellitus in China. Exp Clin Endocrinol Diabetes. 2008;116(1):69-70. (Pubitemid 351270912)
7. Wang K, Li T, Xiang H. Study on the epidemiological characteristics of diabetes mellitus and IGT in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 1998;19(5):282-285.
8. Chen X, Tang L, Chen H, Zhao L, Hu S. Assessing the impact of complications on the costs of type 2 diabetes in urban China [in Chinese]. Chinese Journal of Diabetes. 2003;11(4):238-241.
9. Hu J-P, Rao K-Q, Qian J-C, Wu J. The study of economic burden of chronic non-communicable diseases in China [in Chinese]. Chinese Journal of Prevention and Control of Chronic Non-Communicable Diseases. 2007;15(3):4.
10. Tang L, Chen X, Chen H, Zhao L, Hu S. The financing burden of treatment of diabetes II and its symptom in urban China [in Chinese]. Chinese Health Economics. 2003;250(12):21-23.
11. Du L. A summary analysis and some policy suggestion of the flows of total health expenditure in China [in Chinese]. Chinese Health Economics. 2008;299(1):19-20.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26(suppl 1):S5-20.
13. Jamison DT, Breman JG, Measham AR, et al, eds. Disease Control Priorities in Developing Countries. 2nd ed. A copublication of Oxford University Press and The World Bank. 2006. http://files.dcp2.org/pdf/ DCP/DCPFM.pdf. Accessed June 9, 2009.
14. Haffner SM. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. Int J Clin Pract Suppl. July 2002;(129):33-39. (Pubitemid 34839463)
15. Kohner EM. Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med. 2008;25(suppl 2):20-24.
16. Bilous R. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med. 2008;25(suppl 2):25-29.
17. Radermecker RP, Philips JC, Jandrain B, Paquot N, Scheen AJ. Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials [in French]. Rev Med Liege. 2008;63(7-8):511-518.
18. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance.The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
19. Tuomilehto J, Lindstrom J, Eriksson JG, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 ;344(18):1343-1350.
20. Eriksson KF, Lindgärde F. Prevention of type 2 (non-insulin- dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 1991;34(12):891-898.
21. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
23. China Ministry of Health. Statistics Report on National Health Development (2007). Beijing: Ministry of Health; 2008.
24. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932.
25. Barcelo A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81(1):19-27. (Pubitemid 36168649)
26. Liu Y, Rao K, Wu J, Gakidou E. China's health system performance. Lancet. 2008;372(9653):1914-1923.
27. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia. 2006;49(7):1498-1504. (Pubitemid 43848085)
28. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007 [published correction appears in Diabetes Care. 2008;31(6):1271]. Diabetes Care. 2008;31(3):596-615.
29. Oliva J, Lobo F, Molina B, Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care. 2004;27(11):2616-2621. (Pubitemid 39441460)
30. Nolan JJ, O'Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J. 2006;99(10):307-310. (Pubitemid 44942060)
31. Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care. 2002;8(16 suppl):S441-S449. (Pubitemid 35282605)
32. Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, de Ferranti D. Reform of how health care is paid for in China: challenges and opportunities. Lancet. 2008;372(9652):1846-1853.
33. Wei X, Bamsley J, Zakus D, Cockerill R, Glazier R, Sun X. Evaluation of a diabetes management program in China demonstrated association of improved continuity of care with clinical outcomes. J Clin Epidemiol. 2008;61(9):932-939.
34. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783-1789. (Pubitemid 351697954)
35. Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336(7654):1180-1185.